Health Care/Hospital
iMedX, Inc. Launches Industry Leading Analytics and Business Intelligence with Acquisition of Prevalent, Inc. and Axcension, Inc.
Combined Technology & Teams Will Provide Healthcare Clients Unparalleled Insight into Operations and Billing Functions Existing iMedX Solutions Will Utilize Precision Analytics to Further Increase Efficiency and Boost Cash Flow ATLANTA and KATY, Texas, July 8, 2019 /PRNewswire/ -- iMedX, Inc. (i...
Naturally Healthy Korean Beef Hits the Spot with Proven Health and Well-being Benefits
SEOUL, South Korea, July 8, 2019 /PRNewswire/ -- According to Hanwoo Board, Korean beef has become an increasingly popular choice among health-conscious consumers inHong Kong who are actively seeking out natural, high-quality well-being products. The meteoric rise of Korean beef in the city has t...
ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia
MELBOURNE, Australia, July 6, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch ofGene Therapy in Hemophilia: An ISTH Education Initiative. This landmark launch, the first of its kind in hemophilia, will take place duri...
25 Giant Water Droplets Appear on The Tide on Greenwich Peninsula - London's First Riverside Cultural Linear Park
LONDON, July 4, 2019 /PRNewswire/ -- LA-based conceptual artist, GERONIMO officially opensLondon's newest riverside destination, The Tide on Greenwich Peninsula, with a large-scale installation of 25 vibrant and painterly inflated water droplets. Free for the public to view from 5th-14th July. R...
THE Young University Ranking 2019: Jacobs University Bremen is One of the Best Young Universities in the World
BREMEN, Germany, July 4, 2019 /PRNewswire/ -- Once again, Jacobs University performed excellently in a university ranking. In the 2019 Times Higher Education (THE) Young University Ranking for universities which are younger than 50 years, the international, English-language campus university rank...
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study
LUND, Sweden, 4 July 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company has initiated the second part in its ongoing Phase Ia/b clinical study with KL1333, NeuroVive's candidate drug for chronic treatment of genetic mitochondri...
Week's Top Stories
Most Reposted
10 Start-ups Awarded in HK Tech 300 Southeast Asia Start-up Competition Fostering Innovation & Entrepreneurship Beyond Boundaries
[Picked up by 320 media titles]
2024-06-27 18:56Labuan IBFC Inc. and STEP Malaysia jointly host wealth management and estate planning event
[Picked up by 318 media titles]
2024-06-28 12:45Yidu Tech Announces Annual Results for FY 2024: Existing Business Achieves First Full-Year Profit on Adjusted EBITDA
[Picked up by 291 media titles]
2024-07-01 09:05Hukumonline Launches Comprehensive Law Firm Directory As a Guide for Investment and Business in Indonesia
[Picked up by 285 media titles]
2024-06-28 21:462024 MWC Shanghai | H3C Fully Demonstrates New Achievements in Intelligent Computing, Accelerating the Construction of a New Intelligent Era
[Picked up by 280 media titles]
2024-06-29 01:38